Author Archive

NAM AIDS Map – April 26, 2017

26 April 2017 HIV-positive mothers going hungry in order to pay for formula milk Switching to generic HIV drugs cuts costs without compromising effectiveness Getting access to hepatitis C treatment Editors’ picks from other sources HIV-positive mothers going hungry in order to pay for formula milk Many HIV-positive nursing mothers in London are struggling to […]

The Body PRO – April 25, 2017

Top Stories on TheBodyPRO.com: April 25, 2017 What Needs to Happen for PrEP to Reach All Who Need It? We asked providers and community leaders what they thought needed to happen for PrEP (pre-exposure prophylaxis) to reach everybody who needs it. Read more We’re on Twitter! For even more of the latest HIV updates and […]

 AIDSMAP NEWS  — 18 April 2017 18 April 2017 News from the BHIVA conference London data show that hepatitis C is passed on during anal sex without a condom Around one in five HIV-positive gay men who recently acquired hepatitis C report anal sex without a condom as the only behaviour that could explain their infection. […]

HIV Cure Reportedly Within Reach As Virus “Vanishes” Under New Drug Therapy

Researchers say this is “one of the first serious attempts at a full cure for HIV. by Matthew Tharrett 10/3/2016 British researchers at five UK universities believe they are on track to finding a cure for HIV after developing a new therapy that has essentially “cured” one man of the virus. The 44-year-old man is one of […]

idsmap news: Nurse-led intervention improves adherence

News from aidsmap Nurse-led intervention improves adherence to ART and is cost-effective An antiretroviral therapy (ART) adherence support study conducted in the Netherlands has been hailed as “an outstanding addition to the scientific literature on adherence”. Published in The Lancet Infectious Diseases, the result of the randomised controlled trial showed that a nurse-led adherence support programme […]

aidsmap news: Several new candidates in HIV drug pipeline

More news from CROI 2017 Several new candidates in HIV drug pipeline discussed at conference This year’s Conference on Retroviruses and Opportunistic Infections (CROI 2017), held last month in Seattle, included presentations on several new investigational antiretroviral drugs in development, reflecting a more robust pipeline than we have seen in recent years. Read more >> […]

aidsmap news: More news from CROI 2017, 6 March 2017

More news from CROI 2017 STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive A study of pre-exposure prophylaxis (PrEP) users presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, showed that PrEP users had very high rates of sexually transmitted infection (STI) diagnosis – […]

AIDSMAP UPDATE FROM CROI CONFERENCE – FEBRUARY 20, 2017

News from CROI 2017 Unique case of PrEP failure without drug resistance reported from Amsterdam HIV pre-exposure prophylaxis (PrEP) appears to be nearly 100% effective if taken consistently so that there are high drug levels in the body at the time of exposure to HIV. However, the Conference on Retroviruses and Opportunistic Infections (CROI) held […]

CROI CONFERENCE ON RETROVIRUSES AND OPPORTUNIST INFECTIONS

Friday 17 February 2017 Contents Spanish vaccine induces viral control off ART in nearly 40% of recipients Unique case of PrEP failure without drug resistance Hepatitis C ‘treatment as prevention’ cuts new infections by half Smoking, cancer and heart attacks Good results for three-drug regimen against XDR-TB How should HIV self-testing services be provided? Antiretroviral […]

AIDSMAP UPDATE – JANUARY 23, 2017

News from aidsmap Tenofovir alafenamide approved for hepatitis B in Europe The European Commission has granted marketing authorisation for tenofovir alafenamide, to be sold under the brand name Vemlidy, for the treatment of chronic hepatitis B virus (HBV) infection, according to an announcement from Gilead Sciences. Read more >> Regular small incentives can improve adherence to […]